Maosen Y. Han

State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, Shandong Key Laboratory Of Targeted Drug Delivery And Advanced Pharmaceutics, National Medical Products Administration Key Laboratory For Technology Research And Evaluation Of Drug Products And Key Laboratory Of Chemical Biology
250012, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Engineering immune cells for next-generation therapies.

Engineering immune cells for next-generation therapies.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 30, 2026

Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma.

Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 17, 2026

Synthetic Disaggregators Enhance Central-Peripheral Amyloid-β Clearance in Alzheimer's Disease.

Synthetic Disaggregators Enhance Central-Peripheral Amyloid-β Clearance in Alzheimer's Disease.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: October 11, 2025

In situ generation of EBNA1 CAR-T cells eradicates antigen specific auto-immune B cells for multiple sclerosis treatment.

In situ generation of EBNA1 CAR-T cells eradicates antigen specific auto-immune B cells for multiple sclerosis treatment.

Journal: Acta pharmaceutica Sinica. B
Published: August 27, 2025

Synthetic efferocytic receptor microglia enhances anti-inflammatory clearance of amyloid-β for AD treatment in mice.

Synthetic efferocytic receptor microglia enhances anti-inflammatory clearance of amyloid-β for AD treatment in mice.

Journal: Science advances
Published: July 09, 2025

In vivo CAR-Tfh cell reprogramming restores tolerance in a mouse model of autoimmune hepatitis.

In vivo CAR-Tfh cell reprogramming restores tolerance in a mouse model of autoimmune hepatitis.

Journal: Cell stem cell
Published: June 25, 2025

A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors.

A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors.

Journal: Nature biotechnology
Published: June 05, 2025

TRIM13 in situ engineering boosts anti-inflammatory capacity of CAR-Ms for liver fibrosis therapy.

TRIM13 in situ engineering boosts anti-inflammatory capacity of CAR-Ms for liver fibrosis therapy.

Journal: Nature communications
Published: February 28, 2025

Legumain In Situ Engineering Promotes Efferocytosis of CAR Macrophage to Treat Cardiac Fibrosis.

Legumain In Situ Engineering Promotes Efferocytosis of CAR Macrophage to Treat Cardiac Fibrosis.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: November 17, 2024

Rejuvenation Modulation of Nucleus Pulposus Progenitor Cells Reverses Senescence-Associated Intervertebral Disc Degeneration.

Rejuvenation Modulation of Nucleus Pulposus Progenitor Cells Reverses Senescence-Associated Intervertebral Disc Degeneration.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: July 11, 2024

Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice.

Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice.

Journal: Science advances
Published: June 12, 2024

Using PGT to give birth to hereditary conductive deafness SYNS1 family a healthy offspring: a case report

Using PGT to give birth to hereditary conductive deafness SYNS1 family a healthy offspring: a case report

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: April 01, 2024
Showing 1-12 of 29

Last Updated: 09/26/2026